Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma

World Journal of Gastroenterology

Volumn 21, Issue 22, 2015, Pages 6884-6891

  Qi, Bo ^a   Lu, Jian Guo ^a   Yao, Wen Jian ^a   Chang, Ting Min ^a   Qin, Xiu Guang ^a   Ji, Ying Hua ^a   Wang, Tian Yun ^b   Liu, Shang Guo ^a   Li, Han Chen ^a   Liu, Yu Zhen ^a   Zhao, Bao Sheng ^a  

^a The Third Hospital of Xinxiang Medical University   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Metastasis; miR 382; Outcome; Prognosis

Indexed keywords

FORMALDEHYDE; MICRORNA; MICRORNA 382; RNA; UNCLASSIFIED DRUG; MICRORNA 182; MIRN382 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; HISTOLOGY; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; CANCER MORTALITY; CANCER SIZE; CANCER TISSUE; ESOPHAGUS SURGERY; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; METASTASIS; RNA EXTRACTION; ADJUVANT CHEMOTHERAPY; CARCINOMA, SQUAMOUS CELL; DISEASE COURSE; DISEASE FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS RESECTION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; TIME FACTOR; TUMOR RECURRENCE; VALIDATION STUDY;

AGED; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930858629     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i22.6884     Document Type: Article

References (26)

1. Sun X, Chen W, Chen Z, Wen D, Zhao D, He Y. Populationbased case-control study on risk factors for esophageal cancer in five high-risk areas in China. Asian Pac J Cancer Prev 2010; 11: 1631-1636 [PMID: 21338208]
2. Mao WM, Zheng WH, Ling ZQ. Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev 2011; 12: 2461-2466 [PMID: 22320939]
3. Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/ Latinos, 2012. CA Cancer J Clin 2012; 62: 283-298 [PMID: 22987332 DOI: 10.3322/caac.21153]
4. Zhu ZJ, Hu Y, Zhao YF, Chen XZ, Chen LQ, Chen YT. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma. Ann Thorac Surg 2011; 91: 1502-1508 [PMID: 21354552 DOI: 10.1016/j.athoracsur.2011.01.0 07]
5. Griffin SM, Burt AD, Jennings NA. Lymph node metastasis in early esophageal adenocarcinoma. Ann Surg 2011; 254: 731-76; discussion 731-76; [PMID: 21997815 DOI: 10.1097/ SLA.0b013e318236048b]
6. Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005; 309: 1519-1524 [PMID: 16141061]
7. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol 2012; 13: e249-e258 [PMID: 22652233 DOI: 10.1016/S1470-2045(12)70073-6]
8. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175-205 [PMID: 17506695]
9. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529 [PMID: 12434020]
10. Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, Zhang QY, Shen JH, Xu LY, Li EM. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 2009; 9: 291 [PMID: 19698122 DOI: 10.1186/1471-2407-9-291]
11. He B, Pan Y, Cho WC, Xu Y, Gu L, Nie Z, Chen L, Song G, Gao T, Li R, Wang S. The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One 2012; 7: e49032 [PMID: 23155448 DOI: 10.1371/journal.pone.0049032]
12. Yang M, Liu R, Sheng J, Liao J, Wang Y, Pan E, Guo W, Pu Y, Yin L. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol Rep 2013; 29: 169-176 [PMID: 23124769 DOI: 10.3892/or.2012.2105]
13. Sarver AL, Thayanithy V, Scott MC, Cleton-Jansen AM, Hogendoorn PC, Modiano JF, Subramanian S. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma. Orphanet J Rare Dis 2013; 8: 7 [PMID: 23311495 DOI: 10.1186/1750-1172-8-7]
14. Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT, Chen P, Wang Y, Yan M, Qian Z, Neilly MB, Jin J, Zhang Y, Bohlander SK, Zhang DE, Larson RA, Le Beau MM, Thirman MJ, Golub TR, Rowley JD, Chen J. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA 2008; 105: 15535-15540 [PMID: 18832181 DOI: 10.1073/ pnas.0808266105]
15. Zhao BS, Liu SG, Wang TY, Ji YH, Qi B, Tao YP, Li HC, Wu XN. Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev 2013; 14: 139-143 [PMID: 23534712]
16. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438]
17. Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics 2010; 11: 537-561 [PMID: 21532838 DOI: 10.2174/138920210793175895]
18. Gomes AQ, Nolasco S, Soares H. Non-coding RNAs: multitasking molecules in the cell. Int J Mol Sci 2013; 14: 16010-16039 [PMID: 23912238 DOI: 10.3390/ijms140816010]
19. Liang M. MicroRNA: a new entrance to the broad paradigm of systems molecular medicine. Physiol Genomics 2009; 38: 113-115 [PMID: 19470802 DOI: 10.1152/physiolgenomics.00080.2009]
20. Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J Surg Oncol 2012; 105: 175-182 [PMID: 21882196 DOI: 10.1002/ jso.22066]
21. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, Li B, Meng X, Ma X, Luo M, Shao K, Li N, Qiu B, Mitchelson K, Cheng J, He J. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33 [PMID: 18172293 DOI: 10.1158/0008-5472.CAN-06-4418]
22. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12 [PMID: 16989803]
23. Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, Hagiwara N, Dannenberg AJ, Miyashita M, Croce CM, Harris CC. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009; 15: 6192-6200 [PMID: 19789312 DOI: 10.1158/1078-0432]
24. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008; 135: 255-60; discussion 260 [PMID: 18242245 DOI: 10.1016/ j.jtcvs.2007.08.055]
25. Kong KL, Kwong DL, Chan TH, Law SY, Chen L, Li Y, Qin YR, Guan XY. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2012; 61: 33-42 [PMID: 21813472 DOI: 10.1136/gutjnl-2011-300178]
26. Xu M, Jin H, Xu CX, Sun B, Mao Z, Bi WZ, Wang Y. miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma. Oncotarget 2014; 5: 9472-9483 [PMID: 25344865]